Under construction – not a live service
Sign in
CompletedNo phase

Frailty and Non-Fragile Congenital Heart Disease

Key facts

Who runs it
Hacettepe University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
43 people enrolled
Started
20 Apr 2023
Ended
15 Feb 2024
Type of study
Observational, 2 groups
Treatments tested
  • Observational
Record updated
16 May 2024

Who can take part

Age
15 years to 45 years
Sex
Women and men

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Diagnosed with congenital heart disease
  • To be between the ages of 15-45
  • To have been informed about the study and given written consent to participate in the study

Who cannot take part

  • Having a neurological, orthopedic or any systemic disease,
  • Presence of infection and malignancy,
  • To undergo another surgery other than cardiac surgery
  • Cognitive, psychological and mental status are not suitable for evaluations,

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Congenital heart disease (CHD) is defined as congenital functional or anatomical abnormalities of the heart and intrathoracic great vessels. This study, which is planned to be carried out, will enable people with CHD to present a holistic perspective when planning rehabilitation programs and to create a common language for all health professionals.

The 2 groups in the trial

  • Frail Congenital Heart Disease Group

    Frailty Fried et al. will be evaluated according to the five-parameter criteria set in the Cardiovascular Health Study by Having 3 or more parameters positive is defined as fragility. Individuals who meet this criterion will be included in this group.

    Treatment: Observational

  • Non-frail Congenital Heart Disease Group

    Frailty Fried et al. will be evaluated according to the five-parameter criteria set in the Cardiovascular Health Study by Having 3 or more parameters positive is defined as fragility. Individuals who do not meet this criterion will be included in this group.

    Treatment: Observational

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Investigation of Activities of Daily Living, Cognition and Muscle Strength in Individuals With Frailty and Non-Fragile Congenital Heart Disease
Record updated
16 May 2024